US
Updated
Reviewed by Vidhi Upadhyay
US Intravascular Lithotripsy Market Industry Trends and Forecast to 2034: Segmented by (Application, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $427.8 Mn.
Canada at 22.1% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.81 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $355.9 Mn | — | — |
| 2025 (base) | $427.8 Mn | +$71.9 Mn | — |
| 2026 (forecast) | $514.2 Mn | +$86.4 Mn | +20.2% |
| 2027 (forecast) | $618.1 Mn | +$103.9 Mn | +44.5% |
| 2028 (forecast) | $743.0 Mn | +$124.9 Mn | +73.7% |
| 2029 (forecast) | $893.0 Mn | +$150.1 Mn | +108.7% |
| 2030 (forecast) | $1.07 Bn | +$180.4 Mn | +150.9% |
| 2031 (forecast) | $1.29 Bn | +$216.8 Mn | +201.6% |
| 2032 (forecast) | $1.55 Bn | +$260.6 Mn | +262.5% |
| 2033 (forecast) | $1.86 Bn | +$313.3 Mn | +335.7% |
| 2034 (forecast) | $2.24 Bn | +$376.6 Mn | +423.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$427.8 Mn
China
$88.8 Mn
Canada
$83.9 Mn
Japan
$70.5 Mn
Germany
$46.4 Mn
France
$36.2 Mn
UK
$28.8 Mn
Brazil
$28.5 Mn
Italy
$25.1 Mn
Saudi Arabia
$22.5 Mn
Spain
$21.1 Mn
Ecuador
$21.4 Mn
India
$22.3 Mn
Mexico
$18.6 Mn
Russia
$13.0 Mn
Australia
$12.8 Mn
New Zealand
$11.9 Mn
South Africa
$8.8 Mn
UAE
$5.8 Mn
Egypt
$3.0 Mn
Philippines
$2.8 Mn
Hong Kong
$2.1 Mn
Malaysia
$1.8 Mn
Thailand
$1.5 Mn
Singapore
$1.4 Mn
Kenya
$0.9 Mn
| Market size, 2025 | $427.8 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.24 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 20.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Application, product and end user (see all) |
| Key players | Shockwave Medical (Johnson & Johnson), Boston Scientific Corporation, Abbott Laboratories, FastWave Medical, Amplitude Vascular (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Intravascular lithotripsy uses sound waves inside an artery to crack hard calcium, making it easier to place stents.
Key segments of the intravascular Lithotripsy market include application (Coronary, Peripheral and Aortic Access) and product (Catheters and Generators).
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the intravascular Lithotripsy market.
Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the intravascular Lithotripsy market room to grow.
High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the intravascular Lithotripsy market.
The intravascular Lithotripsy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Boston ScientificThe FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2] Early deaths from long-term diseases: 12.6% in 2023, the latest WHO figure for the US.[3]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how intravascular Lithotripsy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Intravascular Lithotripsy right now, from free public sources.
12.6 %
Early deaths from long-term diseases, US, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
From our blog
US · 2 shared keywords
US · 2 shared keywords
US · 1 shared keyword
US
US
US
Digital Health · US
Pharmaceuticals · US
Pharmaceuticals · US
Pharmaceuticals · US
Pharmaceuticals · US
Healthcare Services · US